| Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification D Ruggero, S Grisendi, F Piazza, E Rego, F Mari, PH Rao, ... Science 299 (5604), 259-262, 2003 | 443 | 2003 |
| Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita A Yoon, G Peng, Y Brandenburg, O Zollo, W Xu, E Rego, D Ruggero Science 312 (5775), 902-906, 2006 | 382 | 2006 |
| Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency M Barna, A Pusic, O Zollo, M Costa, N Kondrashov, E Rego, PH Rao, ... Nature 456 (7224), 971-975, 2008 | 367 | 2008 |
| Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML … EM Rego, LZ He, RP Warrell, ZG Wang, PP Pandolfi Proceedings of the National Academy of Sciences 97 (18), 10173-10178, 2000 | 219 | 2000 |
| Role of promyelocytic leukemia (PML) protein in tumor suppression EM Rego, ZG Wang, D Peruzzi, LZ He, C Cordon-Cardo, PP Pandolfi The Journal of experimental medicine 193 (4), 521-530, 2001 | 177 | 2001 |
| Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer S Wei, S Kozono, L Kats, M Nechama, W Li, J Guarnerio, M Luo, MH You, ... Nature medicine 21 (5), 457-466, 2015 | 171 | 2015 |
| Two critical hits for promyelocytic leukemia LZ He, M Bhaumik, C Tribioli, EM Rego, S Ivins, A Zelent, PP Pandolfi Molecular cell 6 (5), 1131-1141, 2000 | 164 | 2000 |
| Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ... Blood 133 (15), 1630-1643, 2019 | 156 | 2019 |
| Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia FC Guibal, M Alberich-Jorda, H Hirai, A Ebralidze, E Levantini, ... Blood, The Journal of the American Society of Hematology 114 (27), 5415-5425, 2009 | 151 | 2009 |
| Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines RH Jácomo, RAM Melo, FR Souto, ÉR de Mattos, CT de Oliveira, ... Haematologica 92 (10), 1431-1432, 2007 | 133 | 2007 |
| Determination of P‐glycoprotein, MDR‐related protein 1, breast cancer resistance protein, and lung‐resistance protein expression in leukemic stem cells of acute myeloid leukemia LL de Figueiredo‐Pontes, MCT Pintão, LCO Oliveira, LFF Dalmazzo, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2008 | 114 | 2008 |
| Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration RC Ribeiro, E Rego ASH education program book 2006 (1), 162-168, 2006 | 114 | 2006 |
| Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL EM Rego, HT Kim, GJ Ruiz-Argüelles, MS Undurraga, MR Uriarte, ... Blood, The Journal of the American Society of Hematology 121 (11), 1935-1943, 2013 | 104 | 2013 |
| Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene DC Souza-Costa, VC Sandrim, LF Lopes, RF Gerlach, EM Rego, ... Atherosclerosis 193 (2), 438-444, 2007 | 99 | 2007 |
| Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR α, PLZF/RAR α or NPM/RAR α EM Rego, D Ruggero, C Tribioli, G Cattoretti, S Kogan, RL Redner, ... Oncogene 25 (13), 1974-1979, 2006 | 85 | 2006 |
| Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma A Maiolino, VTM Hungria, M Garnica, G Oliveira‐Duarte, LCO Oliveira, ... American journal of hematology 87 (10), 948-952, 2012 | 71 | 2012 |
| Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia HC Kwaan, EM Rego Seminars in thrombosis and hemostasis 36 (08), 917-924, 2010 | 61 | 2010 |
| High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia AR Lucena-Araujo, FM de Oliveira, SD Leite-Cueva, GA dos Santos, ... Leukemia research 35 (2), 260-264, 2011 | 59 | 2011 |
| Age‐related changes of lymphocyte subsets in normal bone marrow biopsies EM Rego, AB Garcia, SR Viana, RP Falcão Cytometry: The Journal of the International Society for Analytical Cytology …, 1998 | 57 | 1998 |
| In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia H Matsushita, PP Scaglioni, M Bhaumik, EM Rego, LF Cai, SM Majid, ... The Journal of experimental medicine 203 (4), 821-828, 2006 | 55 | 2006 |
